Watch CBS News

Even stronger obesity drug could further upend weight-loss care

FDA approval for use of tirzepatide for chronic weight management could come this year, drugmaker Eli Lilly said.
Apr 27, 2023 (00:37)
Videos
View CBS News In
CBS News App Open
Chrome Safari Continue